• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性肝细胞癌。

Inherited hepatocellular carcinoma.

机构信息

HCC Translational Research Laboratory, Barcelona-Clinic Liver Cancer Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Liver Unit, Hospital Clinic, Barcelona, Spain.

出版信息

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):725-34. doi: 10.1016/j.bpg.2010.07.008.

DOI:10.1016/j.bpg.2010.07.008
PMID:20955973
Abstract

Inherited liver disorders that cause chronic inflammation, fibrosis, and cirrhosis can lead to the development of liver cancer. Because of the rarity and diversity of some of these syndromes, the relative risk of developing HCC in these patients and the age at which tumours typically arise cannot be accurately estimated. Among patients with hereditary hemachromatosis (HH), the annual incidence of HCC is 4% once cirrhosis has been established. Fibrosis and portal hypertension associated with HH can be partially reversed with therapeutic phlebotomy, but it is unclear whether this treatment alters the incidence of HCC in these patients. Importantly, it seems likely that coincidence of these genetic disorders with known HCC risk factors such as alcoholism and viral hepatitis would amplify their oncogenic potential. For this reason, patients with known genetic disorders of the liver should be repeatedly counselled to avoid environmental and toxic injury to the liver. Treatment of HCC in patients with inherited liver disease mirrors that of HCC associated with other etiologies. Unfortunately, there are case series which suggest these patients with inherited liver disease and HCC tend to present at more advanced stages and are therefore not eligible for curative therapies, causing overall decreased survival relative to patients with HCC of viral or other etiologies.

摘要

遗传肝脏疾病引起的慢性炎症、纤维化和肝硬化可导致肝癌的发生。由于这些综合征中的一些具有罕见性和多样性,因此无法准确估计这些患者发生 HCC 的相对风险和肿瘤通常出现的年龄。在遗传性血色素沉着症 (HH) 患者中,一旦发生肝硬化,HCC 的年发病率为 4%。HH 相关的纤维化和门静脉高压症可以通过治疗性放血部分逆转,但尚不清楚这种治疗是否会改变这些患者 HCC 的发病率。重要的是,这些遗传疾病与酒精中毒和病毒性肝炎等已知 HCC 危险因素的巧合似乎会放大其致癌潜力。出于这个原因,应反复向已知遗传肝脏疾病的患者提供咨询,以避免环境和肝脏毒性损伤。遗传性肝病患者的 HCC 治疗与其他病因引起的 HCC 治疗相似。不幸的是,有一些病例系列表明,这些患有遗传性肝病和 HCC 的患者往往处于更晚期,因此不符合治愈性治疗的条件,导致与病毒性或其他病因引起的 HCC 患者相比,总体生存率降低。

相似文献

1
Inherited hepatocellular carcinoma.遗传性肝细胞癌。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):725-34. doi: 10.1016/j.bpg.2010.07.008.
2
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的流行病学、筛查、诊断与治疗
Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38.
3
Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.亚太地区肝细胞癌监测计划的应用。
J Gastroenterol Hepatol. 2009 Jun;24(6):955-61. doi: 10.1111/j.1440-1746.2009.05805.x. Epub 2009 Mar 11.
4
[Hepatocellular carcinoma--epidemiology and treatment].[肝细胞癌——流行病学与治疗]
Przegl Epidemiol. 2006;60(4):731-40.
5
Review article: the management of hepatocellular carcinoma.综述文章:肝细胞癌的治疗。
Aliment Pharmacol Ther. 2010 Feb 15;31(4):461-76. doi: 10.1111/j.1365-2036.2009.04200.x. Epub 2009 Nov 19.
6
Factors that affect risk for hepatocellular carcinoma and effects of surveillance.影响肝细胞癌风险的因素和监测的效果。
Clin Gastroenterol Hepatol. 2011 Jul;9(7):617-23.e1. doi: 10.1016/j.cgh.2011.03.027. Epub 2011 Apr 1.
7
Hepatocellular carcinoma in viral hepatitis: improving standard therapy.病毒性肝炎中的肝细胞癌:改进标准治疗方法。
Best Pract Res Clin Gastroenterol. 2008;22(6):1137-51. doi: 10.1016/j.bpg.2008.11.005.
8
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.丙型肝炎相关肝细胞癌肝移植术后生存的预测因素
Liver Transpl. 2004 Dec;10(12):1478-86. doi: 10.1002/lt.20303.
9
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.肝移植前治疗肝癌可降低肝移植后的复发率。
Clin Transplant. 2009 Nov-Dec;23(6):874-81. doi: 10.1111/j.1399-0012.2009.00993.x. Epub 2009 May 4.
10
Established and emerging therapies for hepatocellular carcinoma.用于肝细胞癌的既定和新兴疗法。
Minerva Med. 2010 Dec;101(6):405-18.

引用本文的文献

1
Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma.在一项针对台湾地区肝细胞癌患者的全基因组关联研究中,鉴定出 13 个新的基因座。
Int J Mol Sci. 2023 Nov 16;24(22):16417. doi: 10.3390/ijms242216417.
2
Obesity Management in the Primary Prevention of Hepatocellular Carcinoma.肝细胞癌一级预防中的肥胖管理
Cancers (Basel). 2022 Aug 22;14(16):4051. doi: 10.3390/cancers14164051.
3
Chemopreventive Effect of Dietary Anthocyanins against Gastrointestinal Cancers: A Review of Recent Advances and Perspectives.
膳食花色苷预防胃肠道癌症的作用:最新进展和展望的综述。
Int J Mol Sci. 2020 Sep 8;21(18):6555. doi: 10.3390/ijms21186555.
4
Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients.巴西患者肝母细胞瘤体细胞突变负担的见解
Front Oncol. 2020 May 5;10:556. doi: 10.3389/fonc.2020.00556. eCollection 2020.
5
Hepatocellular Carcinoma: Etiology and Current and Future Drugs.肝细胞癌:病因及现有和未来的药物
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):221-232. doi: 10.1016/j.jceh.2019.01.004. Epub 2019 Jan 25.
6
Liver transplantation for hepatocellular carcinoma.肝细胞癌的肝移植
Hepatobiliary Surg Nutr. 2013 Feb;2(1):22-30. doi: 10.3978/j.issn.2304-3881.2012.11.03.
7
Realizing the promise of cancer predisposition genes.实现癌症易感性基因的承诺。
Nature. 2014 Jan 16;505(7483):302-8. doi: 10.1038/nature12981.
8
Molecular evolution of genetic susceptibility to hepatocellular carcinoma.肝细胞癌遗传易感性的分子进化
Dig Dis Sci. 2014 May;59(5):986-91. doi: 10.1007/s10620-013-2984-3. Epub 2013 Dec 20.
9
Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.利用癌症干细胞标志物分离和鉴定肝癌干细胞的功效。
Stem Cells Dev. 2013 Oct 1;22(19):2655-64. doi: 10.1089/scd.2012.0703. Epub 2013 Jun 8.
10
Hepatocellular carcinoma: natural history, current management, and emerging tools.肝细胞癌:自然史、当前治疗及新兴工具
Biologics. 2012;6:207-19. doi: 10.2147/BTT.S23907. Epub 2012 Jul 17.